Pub Date : 2025-10-13DOI: 10.1016/j.sapharm.2025.10.005
Paul Forsyth , Jessica Baker , Willa Saadat , Andrew Radley
As the duties of pharmacists evolve it can be difficult for many to foster and maintain professional autonomy within both new and core roles. However, it is important for us to understand what autonomy actually means. Autonomy is a common word in every-day use describing a philosophical concept concerning an agent's capacity for self-determination. Professional standards typically try to ensure the required level of individual professional autonomy necessary for pharmacists to deliver care in the best interests of patients. Professional autonomy is a key factor in achieving job satisfaction, meaningful work, and flourishing in a professional role, and when inhibited can lead to negative career experiences and outcomes. Autonomy can however be understood both in this individual sense, linked to liberty and independence, but also in a collective sense, linked to relationships and societal empowerment. This paper examines how pharmacists have understood these differing conceptual views of professional autonomy to date, describing the theoretical basis for each, and then sketching a series of short scenarios that illustrate how the professional autonomy of individual pharmacists can be heavily influenced by many interdependent factors, including relational factors, employment factors, professional factors, and societal factors. Finally, the paper considers the principles and skills needed for pharmacists to create a more stable professional autonomy, both individually and collectively.
{"title":"Professional autonomy in pharmacists: Independence within interdependence","authors":"Paul Forsyth , Jessica Baker , Willa Saadat , Andrew Radley","doi":"10.1016/j.sapharm.2025.10.005","DOIUrl":"10.1016/j.sapharm.2025.10.005","url":null,"abstract":"<div><div>As the duties of pharmacists evolve it can be difficult for many to foster and maintain professional autonomy within both new and core roles. However, it is important for us to understand what autonomy actually means. Autonomy is a common word in every-day use describing a philosophical concept concerning an agent's capacity for self-determination. Professional standards typically try to ensure the required level of individual professional autonomy necessary for pharmacists to deliver care in the best interests of patients. Professional autonomy is a key factor in achieving job satisfaction, meaningful work, and flourishing in a professional role, and when inhibited can lead to negative career experiences and outcomes. Autonomy can however be understood both in this individual sense, linked to liberty and independence, but also in a collective sense, linked to relationships and societal empowerment. This paper examines how pharmacists have understood these differing conceptual views of professional autonomy to date, describing the theoretical basis for each, and then sketching a series of short scenarios that illustrate how the professional autonomy of individual pharmacists can be heavily influenced by many interdependent factors, including relational factors, employment factors, professional factors, and societal factors. Finally, the paper considers the principles and skills needed for pharmacists to create a more stable professional autonomy, both individually and collectively.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 1","pages":"Pages 178-183"},"PeriodicalIF":2.8,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145318646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-13DOI: 10.1016/j.sapharm.2025.10.004
Louisa Handyside , Jacqui Cameron , Christopher Freeman
Background
Engaging pharmacists in research and bridging the research-practice divide is a persistent challenge. Practice-based research networks aim to support research engagement, overcome research barriers, and generate evidence to advance practice. However, the outcomes of existing networks remain unexplored. Thus, the objectives of this realist review are: 1) to develop and refine a realist program theory to explain how and why these networks support research engagement and knowledge translation, for whom and in what contexts and 2) to provide preliminary recommendations to optimise network outcomes.
Methods
An initial program theory was developed, followed by an iterative process of formal and complementary searching. Data was selected, appraised, extracted, organised, and synthesised using a realist approach to refine the program theory.
Results
The refined program theory consisted of 12 context-mechanism-outcome configurations that explain the two key drivers of network success: 1) mutual benefits for a diverse range of actively engaged researchers and pharmacists, and 2) sustainable resourcing and maintenance of strategic collaborative partnerships. Stakeholder recommendations are underpinned by the modifiable contexts and resources that underscore optimal network outcomes.
Conclusion
A realist program theory was developed to explain how research networks may be used to bridge the divide between research and community pharmacy practice. The theory explains the causal processes underpinning successful outcomes and informs preliminary recommendations for network development, implementation, and maintenance. The review provides a robust foundation to explain how networks can optimise community pharmacy research. Futher research is warranted to confirm their translational potential.
{"title":"Enabling real-world community pharmacy research: A realist review of practice-based research networks (PBRNs)","authors":"Louisa Handyside , Jacqui Cameron , Christopher Freeman","doi":"10.1016/j.sapharm.2025.10.004","DOIUrl":"10.1016/j.sapharm.2025.10.004","url":null,"abstract":"<div><h3>Background</h3><div>Engaging pharmacists in research and bridging the research-practice divide is a persistent challenge. Practice-based research networks aim to support research engagement, overcome research barriers, and generate evidence to advance practice. However, the outcomes of existing networks remain unexplored. Thus, the objectives of this realist review are: 1) to develop and refine a realist program theory to explain how and why these networks support research engagement and knowledge translation, for whom and in what contexts and 2) to provide preliminary recommendations to optimise network outcomes.</div></div><div><h3>Methods</h3><div>An initial program theory was developed, followed by an iterative process of formal and complementary searching. Data was selected, appraised, extracted, organised, and synthesised using a realist approach to refine the program theory.</div></div><div><h3>Results</h3><div>The refined program theory consisted of 12 context-mechanism-outcome configurations that explain the two key drivers of network success: 1) mutual benefits for a diverse range of actively engaged researchers and pharmacists, and 2) sustainable resourcing and maintenance of strategic collaborative partnerships. Stakeholder recommendations are underpinned by the modifiable contexts and resources that underscore optimal network outcomes.</div></div><div><h3>Conclusion</h3><div>A realist program theory was developed to explain how research networks may be used to bridge the divide between research and community pharmacy practice. The theory explains the causal processes underpinning successful outcomes and informs preliminary recommendations for network development, implementation, and maintenance. The review provides a robust foundation to explain how networks can optimise community pharmacy research. Futher research is warranted to confirm their translational potential.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 209-221"},"PeriodicalIF":2.8,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145423454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-11DOI: 10.1016/j.sapharm.2025.10.003
Mayyada Wazaify , Christina Steenkamp , Haya Yasin
Purpose
An important, yet under-researched, impact of violent conflict on public health is the susceptibility of populations in conflicts to drug abuse and misuse as increased stress, the easy availability of drugs, and the relaxation of taboos against drug use exacerbate the problem. This study explores the experiences of pharmacists regarding drug misuse and abuse in four conflict-affected MENA countries.
Methods
The study is part of a larger two-year (2021–2023) project investigating the impact of violent conflict in the MENA region on medicine abuse and misuse and the experiences of pharmacists in managing this challenge. This part used a quantitative approach using survey methodology with a sample of pharmacists in Syria, Libya, Yemen and Iraq.
Results
A total of 181 questionnaires were filled (65.7 % male, mean age = 29.9 years old. The majority of the pharmacists (n = 170, 93.9 %) reported that on average, 27.88 % of the pharmacy customers were suspected of misusing/abusing medications in the past 3 months. The most misused medicines were pregabalin and sedatives/hypnotics followed by opioids like tramadol, in addition to cough and cold and anti-allergy preparations. Almost one-third of respondents (31.49 %) refused to dispense drugs which they thought were intended to be used inappropriately. Sixty-five (35.9 %) said that they had been subjected to violence for the sake of obtaining medications, and 17 (9.8 %) reported being threatened five times or more in the past year.
Conclusion
Based on the results above, future interventions in conflict settings must address both supply-side governance and the broader psychosocial drivers of medication misuse/abuse to ensure that pharmacists are supported rather than exposed in their essential work.
{"title":"Pharmacists on the frontline: Medication misuse and abuse during violent conflict in four MENA countries","authors":"Mayyada Wazaify , Christina Steenkamp , Haya Yasin","doi":"10.1016/j.sapharm.2025.10.003","DOIUrl":"10.1016/j.sapharm.2025.10.003","url":null,"abstract":"<div><h3>Purpose</h3><div>An important, yet under-researched, impact of violent conflict on public health is the susceptibility of populations in conflicts to drug abuse and misuse as increased stress, the easy availability of drugs, and the relaxation of taboos against drug use exacerbate the problem. This study explores the experiences of pharmacists regarding drug misuse and abuse in four conflict-affected MENA countries.</div></div><div><h3>Methods</h3><div>The study is part of a larger two-year (2021–2023) project investigating the impact of violent conflict in the MENA region on medicine abuse and misuse and the experiences of pharmacists in managing this challenge. This part used a quantitative approach using survey methodology with a sample of pharmacists in Syria, Libya, Yemen and Iraq.</div></div><div><h3>Results</h3><div>A total of 181 questionnaires were filled (65.7 % male, mean age = 29.9 years old. The majority of the pharmacists (n = 170, 93.9 %) reported that on average, 27.88 % of the pharmacy customers were suspected of misusing/abusing medications in the past 3 months. The most misused medicines were pregabalin and sedatives/hypnotics followed by opioids like tramadol, in addition to cough and cold and anti-allergy preparations. Almost one-third of respondents (31.49 %) refused to dispense drugs which they thought were intended to be used inappropriately. Sixty-five (35.9 %) said that they had been subjected to violence for the sake of obtaining medications, and 17 (9.8 %) reported being threatened five times or more in the past year.</div></div><div><h3>Conclusion</h3><div>Based on the results above, future interventions in conflict settings must address both supply-side governance and the broader psychosocial drivers of medication misuse/abuse to ensure that pharmacists are supported rather than exposed in their essential work.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 283-291"},"PeriodicalIF":2.8,"publicationDate":"2025-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-10DOI: 10.1016/j.sapharm.2025.10.001
Karen R. Palermo , Jesús Cotrina Luque , Natália Marto , Miriam Capoulas , Cláudia Santos , Isabel V. Figueiredo , Margarida Castel-Branco
Background
Medication reconciliation can reduce errors, particularly among elderly and polymedicated patients. The inclusion of pharmacists obtaining the best possible medication history can further improve the identification and resolution of discrepancies.
Aim
To compare a structured pharmacist-led medication reconciliation program with usual care on detecting and resolving discrepancies during hospital admission for major orthopaedic surgeries.
Methods
Quasi-experimental study, conducted in a Portuguese tertiary hospital, involving adult patients undergoing major orthopaedic surgery and taking chronic medication. In Phase One (usual care), reconciliation lacked standardization; pharmacists performed it alongside other tasks, relying solely on medical records and reported unintentional discrepancies electronically to prescribers. In Phase Two (pharmacist-led medication reconciliation), a designated pharmacist obtained the best possible medication history, identified discrepancies and communicated them directly to clinical pharmacologists. Validated high-risk criteria were used to assess clinical significance. Primary outcomes were identifying, classifying, and resolving unintentional discrepancies across both phases.
Results
The study included 182 patients (91 in each phase). In Phase One, 212 discrepancies were identified, 91 were unintentional, of which 30 had clinical significance. Ten pharmacist interventions were performed, with 50 % acceptance rate. In Phase Two, 339 discrepancies were identified, 129 were unintentional, of which 46 had clinical significance. A total of 104 pharmacist interventions were performed, with 73 % acceptance rate. Identification and resolution of unintentional discrepancies significantly increased (p < 0.001).
Conclusion
Pharmacist-led medication reconciliation, focusing on the best possible medication history collection and direct contact with physicians, significantly increased the identification and resolution of discrepancies, underlining its role in enhancing patient safety.
{"title":"Comparison of pharmacist-led medication reconciliation and usual care on detecting and resolving discrepancies in major orthopaedic surgeries: A quasi-experimental study","authors":"Karen R. Palermo , Jesús Cotrina Luque , Natália Marto , Miriam Capoulas , Cláudia Santos , Isabel V. Figueiredo , Margarida Castel-Branco","doi":"10.1016/j.sapharm.2025.10.001","DOIUrl":"10.1016/j.sapharm.2025.10.001","url":null,"abstract":"<div><h3>Background</h3><div>Medication reconciliation can reduce errors, particularly among elderly and polymedicated patients. The inclusion of pharmacists obtaining the best possible medication history can further improve the identification and resolution of discrepancies.</div></div><div><h3>Aim</h3><div>To compare a structured pharmacist-led medication reconciliation program with usual care on detecting and resolving discrepancies during hospital admission for major orthopaedic surgeries.</div></div><div><h3>Methods</h3><div>Quasi-experimental study, conducted in a Portuguese tertiary hospital, involving adult patients undergoing major orthopaedic surgery and taking chronic medication. In Phase One (usual care), reconciliation lacked standardization; pharmacists performed it alongside other tasks, relying solely on medical records and reported unintentional discrepancies electronically to prescribers. In Phase Two (pharmacist-led medication reconciliation), a designated pharmacist obtained the best possible medication history, identified discrepancies and communicated them directly to clinical pharmacologists. Validated high-risk criteria were used to assess clinical significance. Primary outcomes were identifying, classifying, and resolving unintentional discrepancies across both phases.</div></div><div><h3>Results</h3><div>The study included 182 patients (91 in each phase). In Phase One, 212 discrepancies were identified, 91 were unintentional, of which 30 had clinical significance. Ten pharmacist interventions were performed, with 50 % acceptance rate. In Phase Two, 339 discrepancies were identified, 129 were unintentional, of which 46 had clinical significance. A total of 104 pharmacist interventions were performed, with 73 % acceptance rate. Identification and resolution of unintentional discrepancies significantly increased (<em>p</em> < 0.001).</div></div><div><h3>Conclusion</h3><div>Pharmacist-led medication reconciliation, focusing on the best possible medication history collection and direct contact with physicians, significantly increased the identification and resolution of discrepancies, underlining its role in enhancing patient safety.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 263-271"},"PeriodicalIF":2.8,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-06DOI: 10.1016/j.sapharm.2025.10.002
Kah Woon Teoh , Choon Ming Ng , Chun Wie Chong , Yi Ling Ng , J Simon Bell , Shaun Wen Huey Lee
Background
Evidence on the impact of using digital health tools to facilitate prediabetes management in community pharmacies is lacking. This study aimed to evaluate the effects of a digital health-supported and community pharmacy-based lifestyle intervention (PRIME) program on individuals with prediabetes in Malaysia.
Methods
A two-arm cluster randomised controlled trial was conducted in 16 community pharmacies from two states in Malaysia and included people with prediabetes that were overweight or obese. The intervention group received support of in-depth counselling from pharmacists, in-app prediabetes education modules, and peer support, while the usual care group received counselling based on pharmacists’ usual practice. The primary outcomes were the proportion of participants achieving ≥5 % weight loss and differential change in weight. All analyses were performed using intention to treat analyses with mixed effect modelling.
Findings
Ninety-one participants (intervention, n = 46; usual care n = 45) were recruited. At the end of study, participants in the intervention group were twice as likely compared to the usual care group to report a minimum 5 % weight loss (21 % intervention and 7.5 % usual care participants, odds ratio: 2.5, p = 0.266). Intervention group participants also reported a larger weight loss, with a mean difference of 1.26 kg (95 %CI -2.36 kg to −0.15 kg) between groups. These differences were more significant especially among those who were more engaged with PRIME.
Conclusion
The intervention showed greater weight loss than the usual care, but the proportion of individuals achieving clinically meaningful weight loss (≥5 %) was not significant. PRIME program can be an important and useful tool to improve risk factors among individuals with prediabetes especially in a low-resource setting. Further research is needed to determine the economic and long-term sustainability of such programs.
背景:缺乏关于使用数字健康工具促进社区药房糖尿病前期管理的影响的证据。本研究旨在评估马来西亚数字健康支持和基于社区药房的生活方式干预(PRIME)计划对前驱糖尿病患者的影响。方法:在马来西亚两个州的16个社区药房进行了一项双组随机对照试验,其中包括超重或肥胖的前驱糖尿病患者。干预组以药师深度咨询、app内糖尿病前期教育模块、同伴支持为支持,常规护理组以药师惯例为支持。主要结局是体重减轻≥5%的参与者比例和体重差异变化。所有分析均采用混合效应模型进行意向处理分析。结果:招募了91名参与者(干预组,n = 46;常规组,n = 45)。在研究结束时,干预组的参与者报告体重减轻至少5%的可能性是常规护理组的两倍(21%的干预和7.5%的常规护理参与者,优势比:2.5,p = 0.266)。干预组的参与者也报告了更大的体重减轻,组间平均差异为1.26 kg (95% CI -2.36 kg至-0.15 kg)。这些差异更显著,尤其是那些更参与PRIME的人。结论:与常规护理相比,干预显示出更大的体重减轻,但达到临床有意义的体重减轻(≥5%)的个体比例并不显著。PRIME计划可以成为改善糖尿病前期个体风险因素的重要而有用的工具,特别是在资源匮乏的环境中。需要进一步的研究来确定这些项目的经济和长期可持续性。
{"title":"A digital health-supported community pharmacy-based lifestyle intervention program for overweight or obese adults with prediabetes, the PRediabetes Intervention, Management and Evaluation (PRIME) Program: A cluster randomized controlled trial","authors":"Kah Woon Teoh , Choon Ming Ng , Chun Wie Chong , Yi Ling Ng , J Simon Bell , Shaun Wen Huey Lee","doi":"10.1016/j.sapharm.2025.10.002","DOIUrl":"10.1016/j.sapharm.2025.10.002","url":null,"abstract":"<div><h3>Background</h3><div>Evidence on the impact of using digital health tools to facilitate prediabetes management in community pharmacies is lacking. This study aimed to evaluate the effects of a digital health-supported and community pharmacy-based lifestyle intervention (PRIME) program on individuals with prediabetes in Malaysia.</div></div><div><h3>Methods</h3><div>A two-arm cluster randomised controlled trial was conducted in 16 community pharmacies from two states in Malaysia and included people with prediabetes that were overweight or obese. The intervention group received support of in-depth counselling from pharmacists, in-app prediabetes education modules, and peer support, while the usual care group received counselling based on pharmacists’ usual practice. The primary outcomes were the proportion of participants achieving ≥5 % weight loss and differential change in weight. All analyses were performed using intention to treat analyses with mixed effect modelling.</div></div><div><h3>Findings</h3><div>Ninety-one participants (intervention, n = 46; usual care n = 45) were recruited. At the end of study, participants in the intervention group were twice as likely compared to the usual care group to report a minimum 5 % weight loss (21 % intervention and 7.5 % usual care participants, odds ratio: 2.5, p = 0.266). Intervention group participants also reported a larger weight loss, with a mean difference of 1.26 kg (95 %CI -2.36 kg to −0.15 kg) between groups. These differences were more significant especially among those who were more engaged with PRIME.</div></div><div><h3>Conclusion</h3><div>The intervention showed greater weight loss than the usual care, but the proportion of individuals achieving clinically meaningful weight loss (≥5 %) was not significant. PRIME program can be an important and useful tool to improve risk factors among individuals with prediabetes especially in a low-resource setting. Further research is needed to determine the economic and long-term sustainability of such programs.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 272-282"},"PeriodicalIF":2.8,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-03DOI: 10.1016/j.sapharm.2025.09.007
Mitchell Budden , Shalom I. Benrimoj , Francisco Martinez Mardones , Sarah Dineen-Griffin
Background
The term scope of practice (SOP) is gaining increasing traction within the pharmacy profession, reflecting its growing importance. Despite this, definitions and interpretations remain varied, as evidenced by the number of definitions and the variety of synonyms and adjectives used in the literature.
Objectives
(i) To examine the conceptual diversity in terminology used to describe SOP for the pharmacy profession across different jurisdictions; (ii) to propose a curated list of definitions and examples, along with recommended contexts for their application at local, national, and international levels.
Methods
A scoping review was conducted following JBI methodology and reported according to PRISMA-ScR guidelines. PubMed, Scopus, Web of Science, and Embase were searched to January 2025. Grey literature was explored using Google, the Overton database, and other methods. Titles and abstracts of identified records were screened, followed by full-text review against inclusion criteria. Definitions were systematically categorised to identify thematic patterns, overlaps, and distinctions, informing the development of a curated list of SOP definitions for pharmacy.
Results
Of 4,010 peer-reviewed records, 2,106 were screened after removing duplicates, with 31 publications meeting inclusion criteria. An additional 49 grey literature reports were included. A total of 172 definitions were compiled, capturing both phrasing and contextual application of SOP terminology. While no single universally accepted definition emerged, most aligned with three dominant conceptual themes.
Conclusions
The growing focus on pharmacy SOP highlights the need for a more unified and strategic framework. Consolidating definitions into a curated and accessible resource can improve clarity and consistency across educational, clinical, policy, and regulatory domains.
背景:术语实践范围(SOP)在药学专业中越来越受到关注,反映了其日益增长的重要性。尽管如此,定义和解释仍然各不相同,这可以从文学中定义的数量和同义词和形容词的多样性中得到证明。目的:(i)检查不同司法管辖区用于描述药学专业SOP的术语的概念多样性;(ii)提出一份定义和例子的精选清单,以及在地方、国家和国际层面应用这些定义和例子的推荐背景。方法:根据JBI方法进行范围审查,并根据PRISMA-ScR指南进行报告。PubMed, Scopus, Web of Science和Embase被检索到2025年1月。使用谷歌、Overton数据库和其他方法对灰色文献进行了探索。筛选已确定记录的标题和摘要,然后根据纳入标准对全文进行审查。定义被系统地分类,以确定主题模式、重叠和区别,为制定药理学SOP定义的策划清单提供信息。结果:在4010篇同行评议的文献中,剔除重复文献后筛选了2106篇,其中31篇符合纳入标准。另外纳入49份灰色文献报告。总共编制了172个定义,捕获了SOP术语的措辞和上下文应用。虽然没有一个被普遍接受的定义出现,但大多数定义与三个主要概念主题一致。结论:药房SOP越来越受到重视,需要一个更加统一和战略性的框架。将定义整合到一个管理的和可访问的资源中,可以提高跨教育、临床、政策和监管领域的清晰度和一致性。
{"title":"Exploring the concept and definition of scope of practice in pharmacy: A scoping review","authors":"Mitchell Budden , Shalom I. Benrimoj , Francisco Martinez Mardones , Sarah Dineen-Griffin","doi":"10.1016/j.sapharm.2025.09.007","DOIUrl":"10.1016/j.sapharm.2025.09.007","url":null,"abstract":"<div><h3>Background</h3><div>The term <em>scope of practice</em> (SOP) is gaining increasing traction within the pharmacy profession, reflecting its growing importance. Despite this, definitions and interpretations remain varied, as evidenced by the number of definitions and the variety of synonyms and adjectives used in the literature.</div></div><div><h3>Objectives</h3><div>(i) To examine the conceptual diversity in terminology used to describe SOP for the pharmacy profession across different jurisdictions; (ii) to propose a curated list of definitions and examples, along with recommended contexts for their application at local, national, and international levels.</div></div><div><h3>Methods</h3><div>A scoping review was conducted following JBI methodology and reported according to PRISMA-ScR guidelines. PubMed, Scopus, Web of Science, and Embase were searched to January 2025. Grey literature was explored using Google, the Overton database, and other methods. Titles and abstracts of identified records were screened, followed by full-text review against inclusion criteria. Definitions were systematically categorised to identify thematic patterns, overlaps, and distinctions, informing the development of a curated list of SOP definitions for pharmacy.</div></div><div><h3>Results</h3><div>Of 4,010 peer-reviewed records, 2,106 were screened after removing duplicates, with 31 publications meeting inclusion criteria. An additional 49 grey literature reports were included. A total of 172 definitions were compiled, capturing both phrasing and contextual application of SOP terminology. While no single universally accepted definition emerged, most aligned with three dominant conceptual themes.</div></div><div><h3>Conclusions</h3><div>The growing focus on pharmacy SOP highlights the need for a more unified and strategic framework. Consolidating definitions into a curated and accessible resource can improve clarity and consistency across educational, clinical, policy, and regulatory domains.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 195-208"},"PeriodicalIF":2.8,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145233749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-27DOI: 10.1016/j.sapharm.2025.09.006
Hana Amer , Sally Marotti , Imaina Widagdo , Sharon Goldsworthy , Jacinta Johnson , Lisa Kalisch Ellett
Background
Collaborative pharmacist prescribing models have been trialled and implemented in Australian hospitals and involve credentialed pharmacists working with doctors and patients to develop patient medicine plans and prescribe medicines.
Aim
This study aimed to identify pharmacist prescribing policies and procedures in Australian hospitals and provide a narrative summary of the models and associated training.
Method
A scoping study was conducted using an exploratory and descriptive approach to identify and map pharmacist prescribing models implemented in Australian hospitals, and their associated training. Hospital pharmacy directors in Australia were contacted through a hospital pharmacy professional organisation in November 2023 and were asked to provide their pharmacist prescribing policies and procedures. Details of the models and training programs were extracted and summarised, with similarities and differences narratively reported.
Results
Fifteen different collaborative pharmacist prescribing models were reported to be implemented across more than 35 hospitals. Fourteen models had a formal training program. The models varied in scope of practice, particularly relating to medicine initiation and the timing of prescribing. The training and maintenance of currency of practice differed between models. Only three models recognised credentialing from other hospitals.
Conclusion
The study reveals variation in scope of practice, training, and credentialing processes between pharmacist prescribing models, with limited recognition and transferability of prescribing skills across jurisdictions in Australia. Efforts to establish national accreditation standards for pharmacist prescriber education programs and the recent introduction of a national credentialing program, could pave the way for the standardisation of the models and training within Australian hospitals.
{"title":"Collaborative pharmacist prescribing models in Australian hospitals: A scoping study","authors":"Hana Amer , Sally Marotti , Imaina Widagdo , Sharon Goldsworthy , Jacinta Johnson , Lisa Kalisch Ellett","doi":"10.1016/j.sapharm.2025.09.006","DOIUrl":"10.1016/j.sapharm.2025.09.006","url":null,"abstract":"<div><h3>Background</h3><div>Collaborative pharmacist prescribing models have been trialled and implemented in Australian hospitals and involve credentialed pharmacists working with doctors and patients to develop patient medicine plans and prescribe medicines.</div></div><div><h3>Aim</h3><div>This study aimed to identify pharmacist prescribing policies and procedures in Australian hospitals and provide a narrative summary of the models and associated training.</div></div><div><h3>Method</h3><div>A scoping study was conducted using an exploratory and descriptive approach to identify and map pharmacist prescribing models implemented in Australian hospitals, and their associated training. Hospital pharmacy directors in Australia were contacted through a hospital pharmacy professional organisation in November 2023 and were asked to provide their pharmacist prescribing policies and procedures. Details of the models and training programs were extracted and summarised, with similarities and differences narratively reported.</div></div><div><h3>Results</h3><div>Fifteen different collaborative pharmacist prescribing models were reported to be implemented across more than 35 hospitals. Fourteen models had a formal training program. The models varied in scope of practice, particularly relating to medicine initiation and the timing of prescribing. The training and maintenance of currency of practice differed between models. Only three models recognised credentialing from other hospitals.</div></div><div><h3>Conclusion</h3><div>The study reveals variation in scope of practice, training, and credentialing processes between pharmacist prescribing models, with limited recognition and transferability of prescribing skills across jurisdictions in Australia. Efforts to establish national accreditation standards for pharmacist prescriber education programs and the recent introduction of a national credentialing program, could pave the way for the standardisation of the models and training within Australian hospitals.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 185-194"},"PeriodicalIF":2.8,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145245633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The human immunodeficiency virus (HIV) epidemic continues to be a major public health crisis in the United States. Although pre-exposure prophylaxis (PrEP) has emerged as an effective tool to prevent HIV transmission, its uptake and adherence remain suboptimal, especially among high-risk populations. This article explores how the Health Belief Model (HBM) can serve as a guiding framework for pharmacists and other healthcare professionals to enhance PrEP delivery and patient engagement.
Recent literature highlights persistent barriers to PrEP use, including stigma, perceived risk, misinformation, and healthcare access challenges. The five core components of the HBM—perceived severity, perceived susceptibility, perceived benefits, perceived barriers, and cues to action—have been used to understand and design interventions across multiple health behaviors. Studies suggest these components are useful in explaining patient behavior and provider limitations around PrEP, particularly in marginalized communities. While few studies directly apply HBM to PrEP adherence, evidence from related fields supports its predictive power.
The HBM offers a promising lens through which pharmacy-based interventions can be developed to address patient beliefs, reduce stigma, and increase PrEP uptake and adherence. Pharmacists, given their accessibility and trusted role in the community, are uniquely positioned to lead these efforts. Incorporating culturally responsive, HBM-informed strategies in pharmacy practice can significantly improve health outcomes in populations most affected by HIV.
{"title":"Health Belief Model Interventions in Pre-exposure Prophylaxis (PrEP): Untapped intervention in the pharmacy arena","authors":"Alina Cernasev , Holly Angell , Karen Derefinko , Santosh Kumar , Theodore Cory","doi":"10.1016/j.sapharm.2025.09.005","DOIUrl":"10.1016/j.sapharm.2025.09.005","url":null,"abstract":"<div><div>The human immunodeficiency virus (HIV) epidemic continues to be a major public health crisis in the United States. Although pre-exposure prophylaxis (PrEP) has emerged as an effective tool to prevent HIV transmission, its uptake and adherence remain suboptimal, especially among high-risk populations. This article explores how the Health Belief Model (HBM) can serve as a guiding framework for pharmacists and other healthcare professionals to enhance PrEP delivery and patient engagement.</div><div>Recent literature highlights persistent barriers to PrEP use, including stigma, perceived risk, misinformation, and healthcare access challenges. The five core components of the HBM—perceived severity, perceived susceptibility, perceived benefits, perceived barriers, and cues to action—have been used to understand and design interventions across multiple health behaviors. Studies suggest these components are useful in explaining patient behavior and provider limitations around PrEP, particularly in marginalized communities. While few studies directly apply HBM to PrEP adherence, evidence from related fields supports its predictive power.</div><div>The HBM offers a promising lens through which pharmacy-based interventions can be developed to address patient beliefs, reduce stigma, and increase PrEP uptake and adherence. Pharmacists, given their accessibility and trusted role in the community, are uniquely positioned to lead these efforts. Incorporating culturally responsive, HBM-informed strategies in pharmacy practice can significantly improve health outcomes in populations most affected by HIV.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 1","pages":"Pages 171-177"},"PeriodicalIF":2.8,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145208063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The Granada Statements were developed to improve the quality and visibility of pharmacy practice research by encouraging consistency in reporting. However, little is known about how these guidelines are interpreted in low- and middle-income countries (LMICs), where professional roles and services may differ. Examining these perspectives can highlight both barriers and opportunities for wider uptake.
Aim
This study explored how clinical and social pharmacy researchers perceive the Granada Statements, focusing on the challenges, enablers, and strategies that could enhance their application in resource-limited contexts.
Method
A qualitative design was adopted, using focus group discussions with researchers in Türkiye. Data were thematically analyzed through collaborative coding and interpretation. Special attention was given to the Statements’ key areas, including terminology, journal selection, perceptions of relevance, and proposed improvements.
Results
Participants regarded the Statements as a useful framework for clarifying expectations, promoting consistency, and stimulating dialogue about research quality. Barriers included difficulties applying standardized terminology in evolving service contexts, challenges in translating technical terms, undervaluation of LMIC research, financial constraints in open access publishing, and discouraging peer review experiences. Suggested enablers included templates, illustrative examples, modular adoption, culturally sensitive glossaries, and training with editors. A global classification framework for benchmarking pharmacy practice was also proposed.
Conclusion
This study shows that the Granada Statements have the potential to act not only as reporting guidance but also as a framework for more intentional, theory-driven, and globally relevant pharmacy practice research. Flexibility, contextual sensitivity, and institutional support are key to achieving this vision.
{"title":"From global standards to local realities: Understanding the Granada Statements in pharmacy practice research","authors":"Gizem Gülpınar , Aysel Pehlivanlı , Zaheer-Ud-Din Babar","doi":"10.1016/j.sapharm.2025.09.004","DOIUrl":"10.1016/j.sapharm.2025.09.004","url":null,"abstract":"<div><h3>Introduction</h3><div>The Granada Statements were developed to improve the quality and visibility of pharmacy practice research by encouraging consistency in reporting. However, little is known about how these guidelines are interpreted in low- and middle-income countries (LMICs), where professional roles and services may differ. Examining these perspectives can highlight both barriers and opportunities for wider uptake.</div></div><div><h3>Aim</h3><div>This study explored how clinical and social pharmacy researchers perceive the Granada Statements, focusing on the challenges, enablers, and strategies that could enhance their application in resource-limited contexts.</div></div><div><h3>Method</h3><div>A qualitative design was adopted, using focus group discussions with researchers in Türkiye. Data were thematically analyzed through collaborative coding and interpretation. Special attention was given to the Statements’ key areas, including terminology, journal selection, perceptions of relevance, and proposed improvements.</div></div><div><h3>Results</h3><div>Participants regarded the Statements as a useful framework for clarifying expectations, promoting consistency, and stimulating dialogue about research quality. Barriers included difficulties applying standardized terminology in evolving service contexts, challenges in translating technical terms, undervaluation of LMIC research, financial constraints in open access publishing, and discouraging peer review experiences. Suggested enablers included templates, illustrative examples, modular adoption, culturally sensitive glossaries, and training with editors. A global classification framework for benchmarking pharmacy practice was also proposed.</div></div><div><h3>Conclusion</h3><div>This study shows that the Granada Statements have the potential to act not only as reporting guidance but also as a framework for more intentional, theory-driven, and globally relevant pharmacy practice research. Flexibility, contextual sensitivity, and institutional support are key to achieving this vision.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 1","pages":"Pages 162-170"},"PeriodicalIF":2.8,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145087844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-13DOI: 10.1016/j.sapharm.2025.09.001
Chelsea Felkai , Jamie-Lee Carew , David Newby , Joyce Cooper , Hayley Croft
Background
Pharmacists in Australia play a significant role in managing non-prescription medicines and common ailments. The aims of this research were to describe the medication related issues people with intellectual disability face with their common ailments and non-prescription medications and document the recommendations made by pharmacists as part of the medication review process.
Method
A retrospective analysis of medication review reports from credentialed pharmacists performed for a person with intellectual disability between January 2020 and January 2024.
Results
A total of 80 reports were analysed with an average of 6.6 common ailments and 8.0 non-prescription medications per individual with ID. The credentialed pharmacists identified an average of 3.6 issues related to their common ailment or non-prescription medication.
Conclusion
People with intellectual disability have significant issues managing common ailments and non-prescription medicines, that could potentially be more appropriately managed in the primary care setting.
{"title":"Common ailment and non-prescription medication-related problems faced by people with intellectual disability: Findings from medication reviews provided by pharmacists","authors":"Chelsea Felkai , Jamie-Lee Carew , David Newby , Joyce Cooper , Hayley Croft","doi":"10.1016/j.sapharm.2025.09.001","DOIUrl":"10.1016/j.sapharm.2025.09.001","url":null,"abstract":"<div><h3>Background</h3><div>Pharmacists in Australia play a significant role in managing non-prescription medicines and common ailments. The aims of this research were to describe the medication related issues people with intellectual disability face with their common ailments and non-prescription medications and document the recommendations made by pharmacists as part of the medication review process.</div></div><div><h3>Method</h3><div>A retrospective analysis of medication review reports from credentialed pharmacists performed for a person with intellectual disability between January 2020 and January 2024.</div></div><div><h3>Results</h3><div>A total of 80 reports were analysed with an average of 6.6 common ailments and 8.0 non-prescription medications per individual with ID. The credentialed pharmacists identified an average of 3.6 issues related to their common ailment or non-prescription medication.</div></div><div><h3>Conclusion</h3><div>People with intellectual disability have significant issues managing common ailments and non-prescription medicines, that could potentially be more appropriately managed in the primary care setting.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 1","pages":"Pages 128-134"},"PeriodicalIF":2.8,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145126263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}